Skip to content

Ethnopharmacological basis of Huangqin Tang in colorectal cancer: Repurposing a classical formula to overcome PD-1 resistance via lactylation blockade.

Nov 2026 · Journal of Ethnopharmacology · pp. 122536 · 0 citations · 40 references
Medicine

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE Huangqin Tang (HQT), documented in the Shanghan Lun, is traditionally prescribed for "dysenteric disorders" (Li Ji). Modern clinical studies confirm its efficacy against ulcerative colitis and colorectal cancer-associated inflammation, providing a verified traditional basis for investigating its immunomodulatory effects in colorectal malignancy. However, the underlying mechanisms remain unclear.

Aim

OF THE STUDY This study aimed to investigate the regulatory role of lactate-induced protein lactylation in MIF-driven PD-1 resistance and to determine if HQT can reverse this phenotype through metabolic reprogramming.

Materials And Methods

CT26-bearing BALB/c mice were administered HQT intragastrically combined with intraperitoneal anti-PD-1 antibodies. Tumor-infiltrating lymphocytes were profiled by flow cytometry. Integrative transcriptomics and network pharmacology were utilized to screen candidate targets. LC-MS/MS-based lactylomic profiling identified specific modification sites. Lactate modulation assays, and site-directed mutagenesis (NF-κB1 K249R) coupled with rescue experiments were performed in vitro to validate the molecular cascade mechanistically.

Results

HQT synergized with anti-PD-1 to suppress tumor growth and prolong survival. This combination remodeled the immune microenvironment, increasing CD8+ T cells and M1-like macrophages while reducing M2 macrophages and MDSCs. Mechanistically, HQT inhibited tumor glycolysis and lactate production. Lactylomic analysis revealed that lactate induced NF-κB1 lysine 249 (K249) lactylation in CD4+ Tregs, driving MIF transcription. Introducing the K249R mutation abolished lactate-induced MIF expression and reversed immunosuppression. HQT effectively reduced NF-κB1 K249 lactylation, disrupting the MIF-driven feedback loop.

Conclusion

NF-κB1 K249 lactylation acts as a critical post-translational switch linking tumor glycolysis to Treg-mediated immunosuppression. HQT overcomes PD-1 resistance by suppressing this axis. These findings support combining metabolic intervention with immunotherapy and highlight K249 lactylation as a potential biomarker for treatment response.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.